Cash Flow Statement

Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue EBIAT Gross Profit Leases Long-Term Debt Repayments Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Receivables - Other Shares Issued Shares Outstanding Shares Outstanding Shares Repurchased

Ratios

Champions Oncology (CSBR) Shares Issued (2016 - 2026)

Champions Oncology has reported Shares Issued over the past 15 years, most recently at $3000.0 for Q1 2026.

For Q1 2026, Shares Issued fell 92.11% year-over-year to $3000.0; the TTM value through Jan 2026 reached $240000.0, down 23.81%, while the annual FY2025 figure was $320000.0, 26.48% up from the prior year.
Shares Issued for Q1 2026 was $3000.0 at Champions Oncology, down from $207000.0 in the prior quarter.
Over five years, Shares Issued peaked at $276000.0 in Q4 2024 and troughed at -$1000.0 in Q2 2023.
A 5-year average of $75076.9 and a median of $24000.0 in 2025 define the central range for Shares Issued.
Biggest five-year swings in Shares Issued: soared 3300.0% in 2022 and later plummeted 106.25% in 2023.
Year by year, Shares Issued stood at $86000.0 in 2022, then skyrocketed by 179.07% to $240000.0 in 2023, then grew by 15.0% to $276000.0 in 2024, then dropped by 25.0% to $207000.0 in 2025, then tumbled by 98.55% to $3000.0 in 2026.
Business Quant data shows Shares Issued for CSBR at $3000.0 in Q1 2026, $207000.0 in Q4 2025, and $24000.0 in Q3 2025.